NASDAQ
ISRG
Last Price
US $401.27
KEY FIGURES
MKT CAP
$141.8B
EPS
TTM
$8.85
EPS Growth (1Y)
22.59%
PEG
TTM
2.08x
P/E
TTM
45.32x
P/S
TTM
12.89x
YIELD
-
GROWTH (5Y CAGR)
Revenue
Valuation
Financial
Performance
Cash flow to debt coverage
Intuitive Surgical, Inc. cash flow to debt ratio of 1.00K% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Free cash flow growth
Intuitive Surgical, Inc.'s free cash flow has increased 91.03% from $1.30B last year to $2.49B, signaling increasing performance
Debt-to-equity ratio
Intuitive Surgical, Inc.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
Intuitive Surgical, Inc.'s debt has decreased relative to shareholder equity from 0.01 last year to 0.00 today, signaling strengthened financials
Net debt to EBITDA
Intuitive Surgical, Inc. has a net cash position, so leverage is healthy.
Interest coverage
Intuitive Surgical, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.
Profit margin growth
Intuitive Surgical, Inc.'s profit margin has increased (2.29%) in the last year from 27.81% to 28.45%, signaling increasing performance
Current ratio
Intuitive Surgical, Inc.'s short-term assets of $9.78B exceed its short-term liabilities of $2.01B
Return on assets
Intuitive Surgical, Inc.'s return on assets of 15.04% is higher than the 5.00% threshold, indicating efficient asset utilization
Return on equity
Intuitive Surgical, Inc.'s return on equity of 17.83%, is higher than 15.00%, indicating good performance
Earnings quality
Intuitive Surgical, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Earnings stability
Intuitive Surgical, Inc. had positive net income in 5 out of 5 years, indicating stable and consistent earnings
Positive free cash flow
Intuitive Surgical, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Free cash flow yield
Intuitive Surgical, Inc. has a free cash flow yield of 1.79%, which is below the 2.00% threshold, indicating limited cash return relative to market value
Earnings growth
Intuitive Surgical, Inc.'s yearly earnings has increased 22.97% since last year from $2.32B to $2.86B, signaling increasing performance
Revenue growth
Intuitive Surgical, Inc.'s yearly revenue has increased 20.51% since last year from $8.35B to $10.06B, signaling increasing performance
Return on invested capital
ROIC 15.11% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
3-year revenue CAGR
Intuitive Surgical, Inc.'s 3-year revenue CAGR of 17.39% is positive, indicating growing revenue over the past 3 years
Revenue consistency
Intuitive Surgical, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Intuitive Surgical, Inc. had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity
Cash Flow Valuation (DCF)
Intuitive Surgical, Inc. is overvalued relative to its fair value price of 133.11 based on Discounted Cash Flow model
Earnings yield (TTM)
Intuitive Surgical, Inc. has an earnings yield of 2.25%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
EBITDA Valuation
Intuitive Surgical, Inc. is overvalued relative to its fair value price of 80.03 based on EBITDA multiple model
EV/EBITDA (FY)
Intuitive Surgical, Inc. has an EV/EBITDA ratio of 33.43x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
PEG ratio (TTM/FY)
Intuitive Surgical, Inc. has a PEG-ratio over 1 which is considered overvalued
Price-to-book ratio (FY)
Intuitive Surgical, Inc. has a price-to-book ratio of 7.62x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Price-to-sales ratio (TTM)
Intuitive Surgical, Inc. has a price-to-sales ratio of 12.64x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
17.83%
Return on equity
ROIC: 15.11%
Valuation History
45.3X
Price to Earnings
EV/EBITDA: 30.8X
Cash flow
Profit margin
18.22%
EBITDA
24.64%
Cash flow
16.85%
Cash Flow (DCF)
Fair Value
Market $401.27
-66.83%
Default assumptions
EBITDA Multiple
Fair Value
Market $401.27
-80.06%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.